SRS Capital Advisors Inc. acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 1,454 shares of the healthcare conglomerate’s stock, valued at approximately $233,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. The Manufacturers Life Insurance Company bought a new stake in UnitedHealth Group during the third quarter worth $391,839,000. State Street Corp increased its stake in UnitedHealth Group by 5.5% in the fourth quarter. State Street Corp now owns 44,601,975 shares of the healthcare conglomerate’s stock worth $7,138,090,000 after buying an additional 2,306,282 shares during the last quarter. Russell Investments Group Ltd. bought a new stake in UnitedHealth Group during the fourth quarter worth $313,747,000. Asset Management One Co. Ltd. increased its stake in UnitedHealth Group by 1,135.6% in the fourth quarter. Asset Management One Co. Ltd. now owns 1,754,953 shares of the healthcare conglomerate’s stock worth $281,003,000 after buying an additional 1,612,926 shares during the last quarter. Finally, Standard Life Investments LTD increased its stake in UnitedHealth Group by 103.9% in the third quarter. Standard Life Investments LTD now owns 1,960,547 shares of the healthcare conglomerate’s stock worth $274,486,000 after buying an additional 998,999 shares during the last quarter. 86.67% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Inc (NYSE:UNH) traded down 0.22% during midday trading on Friday, reaching $171.16. The company had a trading volume of 2,981,797 shares. UnitedHealth Group Inc has a one year low of $128.53 and a one year high of $172.62. The company has a 50-day moving average price of $167.19 and a 200-day moving average price of $157.47. The stock has a market capitalization of $162.80 billion, a price-to-earnings ratio of 23.61 and a beta of 0.68.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The business had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. During the same period in the previous year, the company earned $1.81 earnings per share. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Inc will post $9.51 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “SRS Capital Advisors Inc. Invests $233,000 in UnitedHealth Group Inc (UNH)” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.com-unik.info/2017/04/21/srs-capital-advisors-inc-invests-233000-in-unitedhealth-group-inc-unh-updated-updated.html.
Several analysts recently weighed in on the company. Credit Suisse Group AG upped their price objective on UnitedHealth Group from $185.00 to $188.00 and gave the stock an “outperform” rating in a research report on Wednesday. Stifel Nicolaus restated a “buy” rating and set a $185.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Evercore ISI restated an “outperform” rating and set a $185.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research report on Tuesday, March 21st. Finally, Mizuho upped their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $181.05.
In other news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Tuesday, January 31st. The shares were sold at an average price of $161.68, for a total transaction of $1,616,800.00. Following the sale, the director now directly owns 1,921,191 shares of the company’s stock, valued at $310,618,160.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Michele J. Hooper sold 15,000 shares of the business’s stock in a transaction on Thursday, March 16th. The shares were sold at an average price of $170.89, for a total transaction of $2,563,350.00. Following the sale, the director now directly owns 35,941 shares in the company, valued at $6,141,957.49. The disclosure for this sale can be found here. Insiders sold 35,310 shares of company stock worth $5,855,416 over the last ninety days. Corporate insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Inc and related companies.